Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
Open Access
- 8 December 2017
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 62 (3) , 1287-1303
Abstract
Following our discovery of a fragment from the repeat domain of tau protein as a structural constituent of the PHF-core in Alzheimer’s disease (AD), we developed an assay that captured several key features of the aggregation process. Tau-tau binding through the core tau fragment could be blocked by the same diaminophenothiazines found to dissolve proteolytically stable PHFs isolated from AD brain. We found that the PHF-core tau fragment is inherently capable of auto-catalytic self-propagation in vitro, or “prion-like processing”, that has now been demonstrated for several neurodegenerative disorders. Here we review the findings that led to the first clinical trials to test tau aggregation inhibitor therapy in AD as a way to block this cascade. Although further trials are still needed, the results to date suggest that a treatment targeting the prion-like processing of tau protein may have a role in both prevention and treatment of AD.Keywords
This publication has 79 references indexed in Scilit:
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivoAutophagy, 2012
- Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutationNeurobiology of Aging, 2011
- Clarifying lysosomal storage diseasesTrends in Neurosciences, 2011
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECTJournal of Nuclear Medicine, 2007
- Mitochondrial damage and intralysosomal degradation in cellular agingMolecular Aspects of Medicine, 2006
- Reduction and uptake of methylene blue by human erythrocytesAmerican Journal of Physiology-Cell Physiology, 2004
- Modeling the Relation Between Neurofibrillary Tangles and Intellectual StatusNeurobiology of Aging, 1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991